The forecast for neoplasms mortality in the US shows a gradual decline from 183.8 deaths per hundred thousand persons in 2024 to 181.5 in 2028. Comparing this with the 2023 data, a consistent decrease in mortality is evident. The year-on-year mortality decrease between 2024 and 2025 is approximately 0.33%. Similarly, from 2025 to 2026, it falls by approximately 0.33%, with the trend continuing through 2028. Over the forecasted period, a compound annual growth rate (CAGR) indicates an annual decline in mortality of approximately 0.31%.
Future trends to watch for include advancements in medical research and treatment for neoplasms, disparities in healthcare access, and policy changes impacting cancer prevention and management. These factors could significantly influence the mortality rates beyond the current forecasts.
